clinical trial · NCT04703868
A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects
Yungjin Pharm. Co., Ltd.·phase1·completed·n = 88
Gastroesophageal Reflux DiseaseRabeprazole Sodium 10mgRabeprazole Sodium 20mg
brief summary
A study to compare the safety, pharmacokinetics and pharmacodynamics of YPI 011 to Rabeprazole in healthy adult subjects
started
Jan 13, 2021
primary completion
Jun 1, 2021
completion
Jun 14, 2021
last updated
Jan 24, 2024
detailed description
This study is to compare the safety, pharmacokinetics and pharmacodynamics of YPI 011 to Rabeprazole in healthy adult subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol